US FDA approves first mRNA flu shot from Moderna

The US FDA has approved Moderna's first mRNA-based flu vaccine, with the company committing to further clinical studies in adults aged 65 and above to confirm efficacy.

This Wire brief sits within Fusion42's coverage of Biotech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.